[1]Siegel RL, Miller KD, Jemal A. Cancer statistics\[J\]. CA Cancer J Clin, 2018, 68(1):7-30.
[2]Momenimovahed Z, Tiznobaik A, Taheri S, et al. Ovarian cancer in the world: epidemiology and risk factors\[J\]. Int J Womens Health, 2019, 11: 287-299.
[3]Bedford MT, Clarke SG. Protein arginine methylation in mammals: who, what, and why\[J\]. Molecular Cell, 2009, 33(1): 1-13.
[4]Ichikawa T, Shanab O, Nakahata S, et al. Novel PRMT5mediated arginine methylations of HSP90A are essential for maintenance of HSP90A function in NDRG2low ATL and various cancer cells\[J\]. Biochim Biophys Acta Mol Cell Res, 2020, 1867(2):118615.
[5]Stopa N, Krebs JE, Shechter D. The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond\[J\]. Cell Mol Life Sci, 2015, 72(11):2041-2059.
[6]Karkhanis V, Alinari L, Ozer HG, et al. Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that downregulate CYCLIN D1 and cMYC expression in aggressive Bcell lymphoma\[J\]. J Biol Chem, 2020, 295(5):1165-1180.
[7]Holmes B, BenavidesSerrato A, Saunders JT, et al. The protein arginine methyltransferase PRMT5 confers therapeutic resistance to mTOR inhibition in glioblastoma\[J\]. J Neurooncol, 2019, 145(1):11-22.
[8]Vinet M, Suresh S, Maire V, et al. Protein arginine methyltransferase 5: A novel therapeutic target for triplenegative breast cancers\[J\]. Cancer Med, 2019, 8(5):2414-2428.
[9]Radzisheuskaya A, Shliaha PV, Grinev V, et al. PRMT5 methylome profiling uncovers a direct link to splicing regulation in acute myeloid leukemia\[J\]. Nat Struct Mol Biol, 2019, 26(11):999-1012.
[10]魏野, 王冉冉, 韩田田, 等. 蛋白质精氨酸甲基转移酶5对人卵巢癌HO8910细胞增殖能力的影响\[J\]. 医学研究生学报, 2018, 31(6):565-572.
[11]Shao G, Wang J, Li Y, et al. Lysinespecific demethylase 1 mediates epidermal growth factor signaling to promote cell migration in ovarian cancer cells\[J\]. Sci Rep, 2015, 5:15344.
[12]Deng X, Shao G, Zhang HT, et al. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth\[J\]. Oncogene, 2017, 36(9): 1223-1231.
[13]Li Y, Wan X, Wei Y, et al. LSD1mediated epigenetic modification contributes to ovarian cancer cell migration and invasion\[J\]. Oncol Rep, 2016, 35(6): 3586-3592.
[14]Shao G, Wang R, Sun A, et al. The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells\[J\]. Mol Cancer, 2018, 17(1): 24.
[15]Shailesh H, Zakaria ZZ, Baiocchi R, et al. Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer\[J\]. Oncotarget, 2018, 9(94):36705-36718.
[16]Zhao T, Jiang W, Wang X, et al. ESE3 inhibits pancreatic cancer metastasis by upregulating Ecadherin\[J\]. Cancer Res, 2017, 77(4):874-885.
|